Tag: iShares U.S. Medical Devices ETF

J&J’s .6B Deal for Abiomed Indicators a New Concentration on Medtech

J&J’s $16.6B Deal for Abiomed Indicators a New Concentration on Medtech

by souhaib

November 1, 2022

Johnson & Johnson introduced an eye-popping health care-product enterprise acquisition early Tuesday, having to pay $16.6 billion upfront for Abiomed ...

Tag: iShares U.S. Medical Devices ETF

J&J’s $16.6B Deal for Abiomed Indicators a New Concentration on Medtech

Recommended

Senate set to approve 235th judge of Biden’s term, beating Trump’s tally

US scraps $10m bounty for arrest of Syria’s new leader Sharaa

Outrage as Elon Musk claims ‘only AfD can save Germany’ | Germany

Indiana Man Sentenced to 130 Years for Killing 2 Teenage Girls – The New York Times

Recent Posts

Categories